Immunotherapy is better than standard 'extreme' chemotherapy as first-line treatment for advanced head and neck cancer and can keep some patients alive for more than three years, a major new trial reports. The immunotherapy drug pembrolizumab alone ...
from Google Alert - health https://ift.tt/2QIGdHj
via IFTTT
0 comments:
Post a Comment